1 |
advanced therapy medicinal product
(88 times)
|
Cell Biology (15 times)
|
GMP (23 times) MSCs (9 times) EMA (6 times)
|
2009 A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice.
|
2 |
aminotris(methylenephosphonic acid)
(15 times)
|
Chemistry (5 times)
|
DTPMP (4 times) HEDP (4 times) AMPA (3 times)
|
2005 Scale inhibition study by turbidity measurement.
|
3 |
amelogenin-trityrosyl-motif-peptide
(3 times)
|
Biochemistry (2 times)
|
GMp (1 time) GMps (1 time) LRAP (1 time)
|
2001 Amelogenin-cytokeratin 14 interaction in ameloblasts during enamel formation.
|
4 |
1-(4-(3-acetyl-2,4,6-triemethylphenyl)-2,6-cyclohexanedionyl)-O-ethyl propionaldehyde oxime
(2 times)
|
Pharmacology (2 times)
|
AIA (1 time) COH (1 time) DDC (1 time)
|
1997 Regulation of CYP 2 A 5 induction by porphyrinogenic agents in mouse primary hepatocytes.
|
5 |
Academy of Translational Medical Professionals
(1 time)
|
Medicine (1 time)
|
EUTMS (1 time) NIH (1 time) TM (1 time)
|
2017 A review of translational medicine. The future paradigm: how can we connect the orthopedic dots better?
|
6 |
ameloblasts binds to trityrosyl motif peptide
(1 time)
|
Biochemistry (1 time)
|
GMp (1 time) PN (1 time)
|
2003 Amelogenin interacts with cytokeratin-5 in ameloblasts during enamel growth.
|
7 |
atmospheric plasma
(1 time)
|
Biocompatible Materials (1 time)
|
Luc (1 time) RED (1 time)
|
2020 Toward Bioluminescent Materials by Plasma Treatment of Microfibrous Nonwovens, Followed by Immobilization of One or Both Enzyme(s) (Luciferase and FMN Reductase) Involved in Luminescent Bacteria.
|
8 |
Automated Timed Manual Performance
(1 time)
|
Geriatrics (1 time)
|
CCRC (1 time) TMP (1 time)
|
1998 On the number of automated timed manual performance trials to administer.
|
9 |
average thickness of moderator band and papillar muscles
(1 time)
|
Cardiology (1 time)
|
AI (1 time) ARVC (1 time) CVG (1 time)
|
1993 [The usefulness of transesophageal echocardiography in the diagnosis of arrhythmogenic cardiomyopathy of the right ventricle].
|